Acne
medications
Medications
|
Dose
|
Select
adverse effects
|
|
Topical
retinoids
|
|||
Tretinoin
|
Once
daily, at bedtime
|
Local
skin irritation, dryness, and flaking; sun sensitivity
NOTE:
Micronized gel tretinoin 0.05% (Atralin) contains soluble fish proteins,
use with caution in patients with known sensitivity or allergy to fish
|
|
Adapalene
|
Once
daily, at bedtime
|
Local
skin irritation, dryness, and flaking; sun sensitivity
|
|
Tazarotene
|
Once
daily, at bedtime
|
Contraindicated
in pregnancy; local skin irritation, dryness, and flaking; sun sensitivity
|
|
Isotretinoin
(not available in United States)
|
Once
daily, at bedtime or twice per day
|
Contraindicated
in pregnancy and lactation; local skin irritation, dryness and flaking; sun
sensitivity
|
|
Topical
antimicrobials*
|
|||
Benzoyl
peroxide (BPO)
|
Twice
daily
|
Local
skin irritation; may bleach hair or clothing
|
|
Clindamycin
|
Twice
daily
Once
daily (foam)
|
Rare
risk of pseudomembranous colitis; usually prescribed with BPO to decrease
resistance
|
|
Erythromycin
|
Twice
daily
|
Usually
prescribed with BPO to decrease resistance
|
|
Dapsone
|
Twice
daily
|
||
Topical
combination products
|
|||
Benzoyl
peroxide 5%/Clindamycin 1%
|
Twice
daily
|
Local
skin irritation; may bleach hair or clothing
|
|
Benzoyl
peroxide 2.5%/Adapalene 0.1%
|
Once
daily
|
Local
skin irritation; may bleach hair or clothing
|
|
Benzoyl
peroxide 2.5%/Adapalene 0.3%
|
Once
daily
|
Local
skin irritation; may bleach hair or clothing
|
|
Azelaic
acid
|
Twice
daily
|
Local
skin irritation
|
|
Salicylic
acid
|
Once to
three times daily
|
Local
skin irritation; potential for salicylate absorption
|
|
Oral
antibiotics¶Δ
|
|||
Tetracycline
|
500 mg
twice daily
|
Photosensitivity,
gastrointestinal distress; contraindicated in pregnancy and young children
|
|
Doxycycline
|
50 to
100 mg twice daily or 100 mg once daily or Delayed release
formulation: 100 mg every 12 hours for one day, then 100 mg per day
Subantimicrobial
dosing: 20 mg twice daily or Delayed release formulation given as 40
mg once daily
|
Photosensitivity,
gastrointestinal distress; contraindicated in pregnancy and young children
|
|
Minocycline
|
50 to
100 mg twice daily or
Extended
release formulation: 1 mg/kg/day (round to nearest available strength)
|
Dizziness,
drug-induced lupus, skin discoloration; contraindicated in pregnancy and
young children
|
|
Erythromycin
|
500 mg
twice daily (base)
|
Gastrointestinal
distress
|
|
Trimethoprim-sulfamethoxazole
|
160
mg/800 mg once to twice daily
|
Stevens-Johnson
syndrome, toxic epidermal necrolysis
|
|
Azithromycin
|
Intermittent
dosing due to long drug half-life; optimum regimen unknown
|
Gastrointestinal
distress
|
|
Hormonal
agents¶◊
|
|||
Combination
oral contraceptives (estrogen/progestin)
|
Once
daily
|
Nausea,
breast tenderness, weight gain, thromboembolic events
|
|
Spironolactone
|
25 to
200 mg/day in one or two equally divided doses; doses of 50 to 100 mg/day may
be as effective as higher doses and reduce side effects
|
Contraindicated
in pregnancy; menstrual irregularity, breast tenderness, minor
gastrointestinal symptoms, orthostatic hypotension, hyperkalemia, dizziness,
headaches, fatigue
|
|
Oral
retinoid§
|
|||
Oral
isotretinoin
|
0.5
mg/kg/day, increasing to 1 mg/kg/day in one or two equally divided doses;
total dose 120 to 150 mg/kg over 20 weeks
|
Teratogenicity
(absolutely contraindicated in pregnancy), mucocutaneous effects,
hypertriglyceridemia, others
|
%:
percent; BPO: Benzoyl peroxide (topical).
* Topical sulfacetamide (eg, gels, creams, lotions, other) with and without sulfur are also available but not typically used and have limited data; refer to topic.
¶ Usual oral dose for adult or adolescent.
Δ BPO may be prescribed with oral antibiotics to reduce resistance.
◊ For additional information refer to topic review of hormonal therapy for acne vulgaris.
§ For additional information refer to topic review of oral isotretinoin therapy for acne vulgaris.
* Topical sulfacetamide (eg, gels, creams, lotions, other) with and without sulfur are also available but not typically used and have limited data; refer to topic.
¶ Usual oral dose for adult or adolescent.
Δ BPO may be prescribed with oral antibiotics to reduce resistance.
◊ For additional information refer to topic review of hormonal therapy for acne vulgaris.
§ For additional information refer to topic review of oral isotretinoin therapy for acne vulgaris.
References:
- www.uptodate.com
- http://www.dermnetnz.org/treatments/isotretinoin.html
- http://www.nhs.uk/conditions/acne/pages/treatment.aspx
- http://www.nps.org.au/publications/health-professional/health-news-evidence/2013/oral-antibiotics-for-acne
- http://emedicine.medscape.com/article/1069804-medication#1
I have you bookmarked your site to check out the new stuff you post.
ReplyDeletehttp;//acnrultimate.com